Safety, Tolerability, Pharmacokinetics, and Antitumor Study of ADCT-601 to Treat Advanced Solid Tumors

NCT03700294 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Stopped Change in clinical plan and drug supply

Conditions

Advanced Solid Tumors

Interventions

DRUG: ADCT-601

Sponsor

ADC Therapeutics S.A.